**Author details**

Teresa Ponce-López1 , Andrew Michael Sorsby-Vargas1 , Alma Patricia Bocanegra-López1 , José Luna-Muñoz<sup>2</sup> , Miguel Angel Ontiveros-Torres3 , Ignacio Villanueva-Fierro4 , Parménides Guadarrama-Ortiz5 and Alejandra Martínez-Maldonado1,2\*

1 Anahuac University North Mexico, Mexico City, Mexico

2 National Brain Bank, Laboratorio Nacional de Servicios Experimentales (LaNSE), Centro de Investigación y Estudios Avanzados del IPN (CINVESTAV-IPN), Mexico City, Mexico

3 Bioengineering Department, Engineering and Sciences School, Tecnológico de Monterrey, Mexico

4 Instituto Politécnico Nacional, Becario COFAA, CIIDIR Durango, Mexico

5 Neurosurgery, Specialized Center in Neurology and Neurosciences, México City, México

\*Address all correspondence to: alemartinez13@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**223**

*Diabetes Mellitus and Amyloid Beta Protein Pathology in Dementia*

their interrelationship? Amyloid.

[10] Zhao HL, Lai FMM, Tong PCY, Zhong DR, Yang D, Tomlinson B, et al. Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes. Diabetes. 2003;**52**(11):2759-2766

[11] Gulli G, Rossetti L, DeFronzo RA. Hyperamylinemia is associated with hyperinsulinemia in the glucosetolerant, insulin-resistant offspring of two Mexican-American noninsulin-dependent diabetic parents. Metabolism. 1997;**46**(10):1157-1161

[12] Zhang S, Liu J, Dragunow M, Cooper GJS. Fibrillogenic amylin evokes islet β-cell apoptosis through linked activation of a caspase cascade and JNK1. The Journal of Biological Chemistry. 2003;**278**(52):52810-52819

[13] Höppener JWM, Verbeek JS, de Koning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, et al. Chronic overproduction of islet amyloid

polypeptide/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia. Diabetologia. 1993;**36**(12):1258-1265

[14] Cadavez L, Montane J, Alcarraz-Vizán G, Visa M, Vidal-Fàbrega L, Servitja JM, et al. Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression. PLoS One.

[15] O'Brien TD, Wagner JD, Litwak KN, Carlson CS, Cefalu WT, Jordan K, et al. Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (*Macaca fascicularis*): An animal model of human non-insulin-dependent diabetes mellitus. Veterinary Pathology.

2014;**9**(7):1-11

1996;**33**(5):479-485

1994;**1**(1):47-60

*DOI: http://dx.doi.org/10.5772/intechopen.84473*

[1] Chen JH, Lin KP, Chen YC. Risk factors for dementia. Journal of the Formosan Medical Association.

classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus.

[3] Moran C, Beare R, Phan TG, Bruce DG, Callisaya ML, Srikanth V. Type 2 diabetes mellitus and biomarkers of neurodegeneration. Neurology.

[4] Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;**387**(10038):2641-2654

[5] Geddes JW, Tekirian TL, Mattson MP. N-terminus truncated beta-amyloid peptides and C-terminus truncated secreted forms of amyloid precursor protein: Distinct roles in the pathogenesis of Alzheimer's disease. Neurobiology of Aging. 1999;**20**(1):75-79. Discussion 87

[6] Kontush A. Alzheimer's amyloid-β as a preventive antioxidant for brain lipoproteins. Cellular and Molecular Neurobiology. 2001;**21**(4):299-315

Alzheimer's disease globular oligomers ADDLs as new vaccine and drug targets. Neurochemistry International.

[8] Alam U, Asghar O, Azmi S, Malik RA. General aspects of diabetes mellitus. In: Handbook of Clinical Neurology. 1st ed. Vol. 126. Netherlands:

Elsevier B.V.; 2014. pp. 211-222

[9] Westermark P. Amyloid and polypeptide hormones: What is

[7] Kelvin WL. Aβ toxicity in

2002;**41**:345-352

**References**

2009;**108**(10):754-764

[2] Alberti KGMM, Zimmet PZ. Definition, diagnosis and

Provisional report of a WHO consultation. Diabetic Medicine.

1998;**15**(7):539-553

2015;**85**(13):1123-1130

*Diabetes Mellitus and Amyloid Beta Protein Pathology in Dementia DOI: http://dx.doi.org/10.5772/intechopen.84473*
